World’s Top AIDS Experts in Brazil for Conference on HIV

The four-day 3rd IAS Conference on HIV Pathogenesis and Treatment, where more than 5,000 doctors and researchers are expected to discuss advances in HIV/AIDS prevention and treatment, began in Rio de Janeiro, Brazil, on Sunday.

A record number of scientific studies will be presented at the conference – organized by the International AIDS Society, in partnership with the Federal University of Rio de Janeiro and Brazil’s Institute of Contagious Diseases – including research focusing on vaccine and treatment developments.


“As the largest scientific AIDS conference of this year, the pathogenesis and treatment conference is an opportunity to explore state-of-the-art scientific developments,” Helene Gayle, IAS president and director of the Bill & Melinda Gates Foundation’s HIV, TB and reproductive health programs, said, adding, “But scientific knowledge alone will not end the pandemic. We need bold political leadership to translate science into policy and practice”


Brazil’s Efforts


Organizers also discussed Brazil’s role in the fight against the pandemic during the opening of the conference.


“Brazil, by maintaining an aggressive and comprehensive approach to HIV prevention, treatment and support is really a leader for our global effort,” Gayle said.


Brazil’s National STD/AIDS Program, which is considered to be one of the most progressive in the world, manufactures and distributes generic versions of antiretroviral drugs, providing them at no cost to all HIV-positive people in the country.


The program ignores all patents issued before 1997, when Brazil signed an intellectual property law in order to join the World Trade Organization.


“Even before antiretroviral therapy was available, (Brazil) had a very lively discourse on HIV and its prevention and its spread, also, a very strong commitment to not stigmatizing people with HIV/AIDS,” Jim Yong Kim, director of the World Health Organization’s HIV/AIDS Program, told BBC News.


However, according to the Associated Press, approximately 50 people from the HIV/AIDS advocacy group Pela Vida (For Life) held a demonstration to protest reports of a recent deal between Brazil’s Ministry of Health and pharmaceutical company Abbott Laboratories.


Earlier this month, Brazil’s Ministry of Health and Abbott said they had reached an agreement for Abbott to keep the government’s annual expenses on Kaletra at current levels for the next six years and that Brazil would not break Abbott’s patent to produce a generic equivalent of the drug.


The Brazilian government had said it would break Abbott’s patent on Kaletra unless the company lowered the drug’s price 42% to 68 cents per pill from its current price of $1.17 per pill.


However, Brazilian Health Minister José Saraiva Felipe, who took office on July 8, later reported that no official agreement had been reached.


Clinical Developments


Also at the conference, Japan’s Ono Pharmaceutical on Monday announced that drug maker GlaxoSmithKline has begun Phase III trials of its experimental antiretroviral called GSK 873140.


The drug, which GSK licensed from Ono, has been in late Phase II trials since last year and aims to prevent HIV from entering human cells.


David Reddy, head of Roche’s HIV/AIDS division, called for increased collaboration, including joint clinical trials, between pharmaceutical companies to prevent the development of drug resistance.


“We’ve almost got all the low-hanging fruit. There is a real uphill battle now, and the potential for the virus to catch up. We are trying to stay one step ahead,” Reddy told the Financial Times. 
 
Kaisernetwork.org

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Criminals Have Already Killed 90 Policemen in São Paulo, This Year

Brazil announced on Tuesday it will create a new police agency, boost surveillance operations ...

Why India Is Decades Ahead of Brazil

Besides religiosity, two things distinguish man from the other animals: walking on two legs ...

Brazil Discovers Sorghum and Is Harvesting Over 1.5 Tons a Year of It

A highly nutritious plant variety used to feed animals, which is being broadly used ...

A Chance to Help in Bahia, Brazil

Thinking about volunteering in Brazil? You should consider Bahia’s AEC-TEA. They are in charming ...

US Market Rises. Brazil Follows the Leader.

Latin American markets rose alongside U.S. market strength. Receding crude oil prices helped boost ...

Concentration of Land Makes No Sense, Says Brazilian Government

According to the Executive Secretary of Brazil’s Ministry of Agrarian Development, Guilherme Cassel, the ...

Febem, São Paulo, Brazil's institution for delinquent minors

Quotas Are Just a Palliative. Brazil Needs Equal Opportunity for All.

One hundred twenty years after the abolition of slavery, two photographs, side by side, ...

Brazil and Ronaldinho from Big Hope to Big Flop

Zinedine Zidane rediscovered his game in Germany, while Ronaldinho left his in Barcelona. Fans ...

Chavez and Lula talk in Brasilia, the capital of Brazil

Lula Signs Oil Partnership with Chavez and Says Time to Say Amen, Amen, Is Over

Brazilian President Luiz Inácio Lula da Silva said that the political will of Brazilian ...